Better outcomes for everybody evaluates the effectiveness and cost-effectiveness of a pharmacist-led intervention, delivered by community pharmacists in collaboration with physicians, in improving disease control, compared with usual care, in asthma and COPD patients during and after COVID-19: A protocol for a pragmatic, parallel randomised controlled trial
Andrea Manfrin, Catherine Jackson, Raffaele Campisi, Alessandro Oteri, Agata Copani, Enrico Desideri, Apostolos Tsiachristas, Paolo Candio, Giulia Di Tomaso, Maria Vitale, Nunzio Crimi
Research output: Contribution to journal › Article › peer-review
13Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Better outcomes for everybody evaluates the effectiveness and cost-effectiveness of a pharmacist-led intervention, delivered by community pharmacists in collaboration with physicians, in improving disease control, compared with usual care, in asthma and COPD patients during and after COVID-19: A protocol for a pragmatic, parallel randomised controlled trial'. Together they form a unique fingerprint.